Michael Scolaro

Michael Scolaro

Nov 16, 2017

Group 6 Copy 123
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Early-Stage Drug Discovery for Chagas' Disease

    An estimated 6 – 7 million people in Latin America and 300,000 U.S. citizens are infected with the protozoan...

    Community-based Leishmaniasis research in Sri Lanka

    Leishmaniasisis a neglected tropical parasitic diseases in the world and is spread by the bite of sand flies...

    Viral Causes of Lung Cancer

    We have special access to blood specimens collected from more than 9,000 cancer free people. These individuals...

    Backer Badge Funded